

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 5.99299501 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.99299501 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.99299501 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.99299501 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.99299501 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.99299501 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.59703606 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.24420544 |
| 9 | negative regulation of cell killing (GO:0031342) | 5.15459015 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.15459015 |
| 11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.09439813 |
| 12 | respiratory burst (GO:0045730) | 5.00777431 |
| 13 | detection of bacterium (GO:0016045) | 4.97739472 |
| 14 | leukocyte aggregation (GO:0070486) | 4.97251855 |
| 15 | neutrophil mediated immunity (GO:0002446) | 4.92313302 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.83431763 |
| 17 | response to peptidoglycan (GO:0032494) | 4.73461953 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.65621961 |
| 19 | detection of external biotic stimulus (GO:0098581) | 4.44196109 |
| 20 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.44124061 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 4.43584880 |
| 22 | * neutrophil activation involved in immune response (GO:0002283) | 4.41436963 |
| 23 | cellular extravasation (GO:0045123) | 4.32532862 |
| 24 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.32322607 |
| 25 | detection of molecule of bacterial origin (GO:0032490) | 4.29598299 |
| 26 | response to host immune response (GO:0052572) | 4.22484489 |
| 27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.22484489 |
| 28 | response to interleukin-15 (GO:0070672) | 4.15837579 |
| 29 | positive regulation of mast cell activation (GO:0033005) | 4.14639422 |
| 30 | positive regulation of interferon-alpha production (GO:0032727) | 4.14192057 |
| 31 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.96386510 |
| 32 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.95941175 |
| 33 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.92655291 |
| 34 | regulation of interferon-alpha production (GO:0032647) | 3.91866837 |
| 35 | detection of biotic stimulus (GO:0009595) | 3.91675683 |
| 36 | response to host defenses (GO:0052200) | 3.88392863 |
| 37 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.88392863 |
| 38 | response to host (GO:0075136) | 3.88392863 |
| 39 | cellular response to interleukin-15 (GO:0071350) | 3.82435676 |
| 40 | negative regulation of T cell mediated immunity (GO:0002710) | 3.81988986 |
| 41 | regulation of mast cell activation (GO:0033003) | 3.81615053 |
| 42 | regulation of mast cell degranulation (GO:0043304) | 3.81102420 |
| 43 | positive regulation of B cell differentiation (GO:0045579) | 3.78191092 |
| 44 | myeloid leukocyte mediated immunity (GO:0002444) | 3.78003302 |
| 45 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.73282035 |
| 46 | positive regulation of antigen processing and presentation (GO:0002579) | 3.68363740 |
| 47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.67767089 |
| 48 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.67767089 |
| 49 | response to muramyl dipeptide (GO:0032495) | 3.65874847 |
| 50 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.64887580 |
| 51 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.64215061 |
| 52 | * myeloid cell activation involved in immune response (GO:0002275) | 3.59872246 |
| 53 | * neutrophil activation (GO:0042119) | 3.59582978 |
| 54 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.58154611 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.58065606 |
| 56 | natural killer cell mediated immunity (GO:0002228) | 3.57775812 |
| 57 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.57775812 |
| 58 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.56030018 |
| 59 | regulation of B cell differentiation (GO:0045577) | 3.53801613 |
| 60 | * granulocyte activation (GO:0036230) | 3.53591384 |
| 61 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.50496010 |
| 62 | leukocyte mediated cytotoxicity (GO:0001909) | 3.47884181 |
| 63 | B cell mediated immunity (GO:0019724) | 3.47109440 |
| 64 | regulation of T cell tolerance induction (GO:0002664) | 3.46785913 |
| 65 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.43868306 |
| 66 | microglial cell activation (GO:0001774) | 3.41492860 |
| 67 | pinocytosis (GO:0006907) | 3.40519347 |
| 68 | regulation of tolerance induction (GO:0002643) | 3.40380711 |
| 69 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.34659885 |
| 70 | regulation of leukocyte degranulation (GO:0043300) | 3.34442403 |
| 71 | activated T cell proliferation (GO:0050798) | 3.34397340 |
| 72 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.33463690 |
| 73 | positive regulation of mast cell degranulation (GO:0043306) | 3.33463690 |
| 74 | negative thymic T cell selection (GO:0045060) | 3.33000758 |
| 75 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.31471634 |
| 76 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.31036340 |
| 77 | defense response to protozoan (GO:0042832) | 3.29742921 |
| 78 | B cell receptor signaling pathway (GO:0050853) | 3.26780248 |
| 79 | negative T cell selection (GO:0043383) | 3.25097683 |
| 80 | neutrophil chemotaxis (GO:0030593) | 3.22518980 |
| 81 | leukocyte cell-cell adhesion (GO:0007159) | 3.22407360 |
| 82 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.21197050 |
| 83 | regulation of gamma-delta T cell activation (GO:0046643) | 3.19071722 |
| 84 | positive regulation of interferon-beta production (GO:0032728) | 3.16679645 |
| 85 | response to fungus (GO:0009620) | 3.16461306 |
| 86 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.14352709 |
| 87 | negative regulation of interleukin-12 production (GO:0032695) | 3.14215906 |
| 88 | neutrophil migration (GO:1990266) | 3.13139145 |
| 89 | regulation of antigen processing and presentation (GO:0002577) | 3.11846630 |
| 90 | negative regulation of phagocytosis (GO:0050765) | 3.11649541 |
| 91 | macrophage activation (GO:0042116) | 3.11522050 |
| 92 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.10897381 |
| 93 | cellular response to zinc ion (GO:0071294) | 3.10772443 |
| 94 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.10742308 |
| 95 | reactive oxygen species biosynthetic process (GO:1903409) | 3.09093571 |
| 96 | superoxide anion generation (GO:0042554) | 3.08846544 |
| 97 | regulation of regulated secretory pathway (GO:1903305) | 3.07642896 |
| 98 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.04457949 |
| 99 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.04457949 |
| 100 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.03400580 |
| 101 | response to protozoan (GO:0001562) | 3.02156596 |
| 102 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.02108946 |
| 103 | dendritic cell migration (GO:0036336) | 3.01966042 |
| 104 | negative regulation of innate immune response (GO:0045824) | 3.00783502 |
| 105 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.00769286 |
| 106 | tolerance induction (GO:0002507) | 3.00242212 |
| 107 | T cell migration (GO:0072678) | 2.97630027 |
| 108 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.97193730 |
| 109 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.96167187 |
| 110 | dendritic cell chemotaxis (GO:0002407) | 2.94923877 |
| 111 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.94702035 |
| 112 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.94654725 |
| 113 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.94394520 |
| 114 | negative regulation of type 2 immune response (GO:0002829) | 2.93944154 |
| 115 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.92535278 |
| 116 | actin nucleation (GO:0045010) | 2.91077490 |
| 117 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.90490538 |
| 118 | negative regulation of mast cell activation (GO:0033004) | 2.89638361 |
| 119 | mast cell activation (GO:0045576) | 2.87719469 |
| 120 | detection of other organism (GO:0098543) | 2.87554515 |
| 121 | positive thymic T cell selection (GO:0045059) | 2.84822978 |
| 122 | cellular response to type I interferon (GO:0071357) | 2.77776636 |
| 123 | type I interferon signaling pathway (GO:0060337) | 2.77776636 |
| 124 | germinal center formation (GO:0002467) | 2.77339383 |
| 125 | response to type I interferon (GO:0034340) | 2.77218459 |
| 126 | leukocyte mediated immunity (GO:0002443) | 2.76833454 |
| 127 | * myeloid leukocyte activation (GO:0002274) | 2.76625458 |
| 128 | positive regulation of leukocyte degranulation (GO:0043302) | 2.75791744 |
| 129 | lymphocyte mediated immunity (GO:0002449) | 2.75520637 |
| 130 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.75222899 |
| 131 | leukotriene metabolic process (GO:0006691) | 2.74200299 |
| 132 | negative regulation of interleukin-6 production (GO:0032715) | 2.74130702 |
| 133 | myeloid dendritic cell activation (GO:0001773) | 2.74025114 |
| 134 | granulocyte chemotaxis (GO:0071621) | 2.73944392 |
| 135 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.73859953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.95803888 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.61650811 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.31989004 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.12212336 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.09458669 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.96172933 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.63368370 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.51420000 |
| 9 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.49597261 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.25971186 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.21045117 |
| 12 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.19962303 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.04983156 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.96015813 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.85597193 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.68331970 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.68116750 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.68063671 |
| 19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.65223596 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.57442034 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.54166580 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.49174955 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.45351386 |
| 24 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35746259 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.26409566 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.22414112 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.20224541 |
| 28 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.08743171 |
| 29 | * MYB_26560356_Chip-Seq_TH2_Human | 2.07198604 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.05397460 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.04694114 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.03084314 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 2.00120004 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.92292717 |
| 35 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.90481696 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.88704621 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87655996 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.83861582 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81089991 |
| 40 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78002543 |
| 41 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.75770784 |
| 42 | MYC_22102868_ChIP-Seq_BL_Human | 1.69589936 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.66390122 |
| 44 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62494997 |
| 45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.61463500 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.61451980 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57413915 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55850254 |
| 49 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.54381615 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51485326 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47932596 |
| 52 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47778513 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43423570 |
| 54 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40708194 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.39487721 |
| 56 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37665776 |
| 57 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35460002 |
| 58 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.34504494 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30878264 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29686039 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29550292 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29250969 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25090640 |
| 64 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.24840154 |
| 65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22790659 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.22070646 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20567937 |
| 68 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19717945 |
| 69 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19171834 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17153220 |
| 71 | * MAF_26560356_Chip-Seq_TH2_Human | 1.16058426 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15172478 |
| 73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14614484 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13698589 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12809946 |
| 76 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12105155 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11798480 |
| 78 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07423958 |
| 79 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06741095 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05965024 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03681132 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03324191 |
| 83 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03242046 |
| 84 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.99322101 |
| 85 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98226952 |
| 86 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97090544 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96970857 |
| 88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96896589 |
| 89 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.91657984 |
| 90 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91108836 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90678247 |
| 92 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86508740 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85911501 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84921872 |
| 95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84286954 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82081802 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79850441 |
| 98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76647998 |
| 99 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.76104480 |
| 100 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.75888090 |
| 101 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.75734066 |
| 102 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.74697492 |
| 103 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.71206800 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.66959974 |
| 105 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.65104925 |
| 106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64600372 |
| 107 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.64511428 |
| 108 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64423751 |
| 109 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63862643 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.61619839 |
| 111 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.59953017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.03522958 |
| 2 | MP0003436_decreased_susceptibility_to | 3.69410376 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.68125088 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.45550264 |
| 5 | MP0003303_peritoneal_inflammation | 3.25662189 |
| 6 | * MP0002419_abnormal_innate_immunity | 3.23543500 |
| 7 | MP0003172_abnormal_lysosome_physiology | 3.18296905 |
| 8 | MP0009785_altered_susceptibility_to | 3.08153066 |
| 9 | MP0006082_CNS_inflammation | 2.94392803 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.86184085 |
| 11 | MP0005025_abnormal_response_to | 2.80667296 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.65575658 |
| 13 | MP0005671_abnormal_response_to | 2.65431615 |
| 14 | MP0001800_abnormal_humoral_immune | 2.58857320 |
| 15 | MP0005387_immune_system_phenotype | 2.53758376 |
| 16 | MP0001790_abnormal_immune_system | 2.53758376 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.52218409 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.47528944 |
| 19 | MP0000685_abnormal_immune_system | 2.47328613 |
| 20 | MP0002723_abnormal_immune_serum | 2.46228657 |
| 21 | * MP0001819_abnormal_immune_cell | 2.40396540 |
| 22 | * MP0002420_abnormal_adaptive_immunity | 2.39724012 |
| 23 | MP0009278_abnormal_bone_marrow | 2.26874266 |
| 24 | MP0003724_increased_susceptibility_to | 2.13190838 |
| 25 | MP0005174_abnormal_tail_pigmentation | 2.10356497 |
| 26 | MP0002405_respiratory_system_inflammati | 2.08928713 |
| 27 | MP0003183_abnormal_peptide_metabolism | 2.07020945 |
| 28 | MP0004510_myositis | 1.98382007 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.91524267 |
| 30 | MP0002132_abnormal_respiratory_system | 1.84533102 |
| 31 | MP0002398_abnormal_bone_marrow | 1.82812013 |
| 32 | MP0000716_abnormal_immune_system | 1.81912757 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.80098374 |
| 34 | MP0004947_skin_inflammation | 1.78889918 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.78706661 |
| 36 | MP0001853_heart_inflammation | 1.72575619 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.72367601 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.69673536 |
| 39 | MP0003448_altered_tumor_morphology | 1.68997472 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.68215370 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.66711502 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.66711502 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.64985283 |
| 44 | MP0000858_altered_metastatic_potential | 1.63758195 |
| 45 | MP0002006_tumorigenesis | 1.54268765 |
| 46 | MP0002722_abnormal_immune_system | 1.53858768 |
| 47 | MP0009840_abnormal_foam_cell | 1.53841732 |
| 48 | MP0000015_abnormal_ear_pigmentation | 1.53189324 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.52552187 |
| 50 | MP0000343_altered_response_to | 1.51862799 |
| 51 | MP0002429_abnormal_blood_cell | 1.51194587 |
| 52 | MP0008469_abnormal_protein_level | 1.49455594 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.49381543 |
| 54 | MP0004381_abnormal_hair_follicle | 1.47742527 |
| 55 | MP0005451_abnormal_body_composition | 1.47472417 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.45758690 |
| 57 | MP0010307_abnormal_tumor_latency | 1.41525673 |
| 58 | MP0003763_abnormal_thymus_physiology | 1.41386539 |
| 59 | MP0001851_eye_inflammation | 1.39892186 |
| 60 | MP0001873_stomach_inflammation | 1.37590873 |
| 61 | MP0003075_altered_response_to | 1.35045751 |
| 62 | MP0005310_abnormal_salivary_gland | 1.32765628 |
| 63 | MP0000604_amyloidosis | 1.27298380 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 1.25014553 |
| 65 | MP0002933_joint_inflammation | 1.24887370 |
| 66 | MP0009764_decreased_sensitivity_to | 1.23316096 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.21889072 |
| 68 | MP0003690_abnormal_glial_cell | 1.13503339 |
| 69 | MP0005166_decreased_susceptibility_to | 1.10094721 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.09851489 |
| 71 | MP0001958_emphysema | 1.05768181 |
| 72 | MP0000703_abnormal_thymus_morphology | 1.05219317 |
| 73 | MP0000371_diluted_coat_color | 1.03637059 |
| 74 | MP0009763_increased_sensitivity_to | 0.95412850 |
| 75 | MP0000490_abnormal_crypts_of | 0.94268643 |
| 76 | MP0005076_abnormal_cell_differentiation | 0.92588712 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.90725447 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 0.90511675 |
| 79 | MP0003828_pulmonary_edema | 0.84147511 |
| 80 | MP0005257_abnormal_intraocular_pressure | 0.82238425 |
| 81 | MP0005390_skeleton_phenotype | 0.80923577 |
| 82 | MP0003866_abnormal_defecation | 0.80577969 |
| 83 | MP0008004_abnormal_stomach_pH | 0.79386405 |
| 84 | MP0002277_abnormal_respiratory_mucosa | 0.79170117 |
| 85 | MP0008260_abnormal_autophagy | 0.78919119 |
| 86 | MP0005075_abnormal_melanosome_morpholog | 0.78180627 |
| 87 | MP0003045_fibrosis | 0.74971383 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 0.72849502 |
| 89 | MP0004130_abnormal_muscle_cell | 0.69205898 |
| 90 | MP0000249_abnormal_blood_vessel | 0.68795853 |
| 91 | MP0003795_abnormal_bone_structure | 0.68065932 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.66870541 |
| 93 | MP0005023_abnormal_wound_healing | 0.66622495 |
| 94 | * MP0003566_abnormal_cell_adhesion | 0.66204399 |
| 95 | MP0002019_abnormal_tumor_incidence | 0.65823470 |
| 96 | MP0005164_abnormal_response_to | 0.64042054 |
| 97 | MP0008874_decreased_physiological_sensi | 0.61940430 |
| 98 | MP0002095_abnormal_skin_pigmentation | 0.61642041 |
| 99 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57874196 |
| 100 | MP0001663_abnormal_digestive_system | 0.56939268 |
| 101 | MP0003091_abnormal_cell_migration | 0.55635034 |
| 102 | MP0002138_abnormal_hepatobiliary_system | 0.54128214 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.54052687 |
| 104 | MP0000920_abnormal_myelination | 0.53564648 |
| 105 | MP0002133_abnormal_respiratory_system | 0.53345188 |
| 106 | MP0005388_respiratory_system_phenotype | 0.53345188 |
| 107 | MP0005377_hearing/vestibular/ear_phenot | 0.51733916 |
| 108 | MP0003878_abnormal_ear_physiology | 0.51733916 |
| 109 | MP0002332_abnormal_exercise_endurance | 0.51245145 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.48458708 |
| 111 | MP0004883_abnormal_blood_vessel | 0.48255727 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.45832894 |
| 113 | MP0003279_aneurysm | 0.45717294 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.45331985 |
| 115 | MP0000598_abnormal_liver_morphology | 0.44857346 |
| 116 | MP0008873_increased_physiological_sensi | 0.44587038 |
| 117 | MP0010352_gastrointestinal_tract_polyps | 0.44295741 |
| 118 | MP0000767_abnormal_smooth_muscle | 0.43852354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.92356955 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.93956129 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.63675838 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.81398315 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 5.26434835 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.10015404 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 5.07903441 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.58209727 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 4.38673505 |
| 10 | Obstructive lung disease (HP:0006536) | 4.38673505 |
| 11 | Gingivitis (HP:0000230) | 4.37701477 |
| 12 | Recurrent skin infections (HP:0001581) | 4.35698447 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.34797124 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 4.27867245 |
| 15 | Myositis (HP:0100614) | 4.17700944 |
| 16 | Recurrent fungal infections (HP:0002841) | 4.05383633 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.98911358 |
| 18 | Encephalitis (HP:0002383) | 3.79331604 |
| 19 | Stomatitis (HP:0010280) | 3.69862111 |
| 20 | Hypochromic microcytic anemia (HP:0004840) | 3.67070298 |
| 21 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.63938209 |
| 22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.63938209 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 3.63938209 |
| 24 | Increased IgE level (HP:0003212) | 3.62755171 |
| 25 | Dysostosis multiplex (HP:0000943) | 3.57490265 |
| 26 | Autoimmune thrombocytopenia (HP:0001973) | 3.55488804 |
| 27 | Keratoconjunctivitis (HP:0001096) | 3.47852854 |
| 28 | Periodontitis (HP:0000704) | 3.39887277 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 3.37042567 |
| 30 | Disinhibition (HP:0000734) | 3.34524321 |
| 31 | Orchitis (HP:0100796) | 3.30649066 |
| 32 | Hypochromic anemia (HP:0001931) | 3.29851460 |
| 33 | Recurrent cutaneous fungal infections (HP:0011370) | 3.14188287 |
| 34 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.14188287 |
| 35 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.12207827 |
| 36 | Episodic fever (HP:0001954) | 3.12142776 |
| 37 | Recurrent viral infections (HP:0004429) | 3.10573795 |
| 38 | Spontaneous hematomas (HP:0007420) | 3.04680439 |
| 39 | Optic neuritis (HP:0100653) | 3.00893411 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 3.00893411 |
| 41 | Axonal loss (HP:0003447) | 2.98320881 |
| 42 | Cellulitis (HP:0100658) | 2.97496382 |
| 43 | Pustule (HP:0200039) | 2.97338315 |
| 44 | Meningitis (HP:0001287) | 2.93885076 |
| 45 | Mucopolysacchariduria (HP:0008155) | 2.90342611 |
| 46 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.90342611 |
| 47 | Agnosia (HP:0010524) | 2.87574278 |
| 48 | Vasculitis (HP:0002633) | 2.87393919 |
| 49 | Urticaria (HP:0001025) | 2.85613877 |
| 50 | Loss of speech (HP:0002371) | 2.85132968 |
| 51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.83793481 |
| 52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.83793481 |
| 53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.83793481 |
| 54 | Amyloidosis (HP:0011034) | 2.81534364 |
| 55 | Peritonitis (HP:0002586) | 2.76872315 |
| 56 | Leukocytosis (HP:0001974) | 2.76111828 |
| 57 | Panhypogammaglobulinemia (HP:0003139) | 2.72429512 |
| 58 | Anorexia (HP:0002039) | 2.72422293 |
| 59 | Pulmonary embolism (HP:0002204) | 2.72262632 |
| 60 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.60488305 |
| 61 | Hematochezia (HP:0002573) | 2.58605100 |
| 62 | Osteomyelitis (HP:0002754) | 2.58477995 |
| 63 | Prostate neoplasm (HP:0100787) | 2.57746809 |
| 64 | Hepatosplenomegaly (HP:0001433) | 2.57372433 |
| 65 | Increased IgM level (HP:0003496) | 2.53896102 |
| 66 | Microcytic anemia (HP:0001935) | 2.48459900 |
| 67 | Gingival bleeding (HP:0000225) | 2.42218432 |
| 68 | IgM deficiency (HP:0002850) | 2.40197969 |
| 69 | Epistaxis (HP:0000421) | 2.38238582 |
| 70 | Glomerulonephritis (HP:0000099) | 2.37384033 |
| 71 | Prolonged bleeding time (HP:0003010) | 2.37310872 |
| 72 | Hemoptysis (HP:0002105) | 2.36933780 |
| 73 | Chronic otitis media (HP:0000389) | 2.36575133 |
| 74 | Basal ganglia calcification (HP:0002135) | 2.36289622 |
| 75 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.33583630 |
| 76 | T lymphocytopenia (HP:0005403) | 2.30232241 |
| 77 | Thoracic kyphosis (HP:0002942) | 2.29752682 |
| 78 | Inflammation of the large intestine (HP:0002037) | 2.29729980 |
| 79 | Abnormality of T cell number (HP:0011839) | 2.29639473 |
| 80 | Pulmonary infiltrates (HP:0002113) | 2.29022789 |
| 81 | Abnormality of the pleura (HP:0002103) | 2.28548154 |
| 82 | Lymphopenia (HP:0001888) | 2.26888948 |
| 83 | Petechiae (HP:0000967) | 2.26410750 |
| 84 | Abnormality of T cell physiology (HP:0011840) | 2.26265118 |
| 85 | Gangrene (HP:0100758) | 2.26048304 |
| 86 | Recurrent pneumonia (HP:0006532) | 2.25735612 |
| 87 | Upper motor neuron abnormality (HP:0002127) | 2.25561297 |
| 88 | Abnormality of the prostate (HP:0008775) | 2.22072113 |
| 89 | Hypergammaglobulinemia (HP:0010702) | 2.21626988 |
| 90 | Interstitial pulmonary disease (HP:0006530) | 2.21514771 |
| 91 | Eosinophilia (HP:0001880) | 2.21073688 |
| 92 | Thyroiditis (HP:0100646) | 2.19031198 |
| 93 | Gastrointestinal inflammation (HP:0004386) | 2.16830930 |
| 94 | Arterial thrombosis (HP:0004420) | 2.16689555 |
| 95 | Purpura (HP:0000979) | 2.15795090 |
| 96 | Abnormality of the peritoneum (HP:0002585) | 2.14236288 |
| 97 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.13822489 |
| 98 | Pathologic fracture (HP:0002756) | 2.10858364 |
| 99 | Glomerulopathy (HP:0100820) | 2.10453556 |
| 100 | Increased serum ferritin (HP:0003281) | 2.10090334 |
| 101 | Thick nail (HP:0001805) | 2.09268955 |
| 102 | Abnormality of the endocardium (HP:0004306) | 2.08121670 |
| 103 | Colitis (HP:0002583) | 2.05951253 |
| 104 | Slow saccadic eye movements (HP:0000514) | 2.05763933 |
| 105 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.04200091 |
| 106 | Abnormality of eosinophils (HP:0001879) | 2.02749777 |
| 107 | Abnormality of iron homeostasis (HP:0011031) | 2.01853418 |
| 108 | Premature loss of primary teeth (HP:0006323) | 2.01091270 |
| 109 | Acne (HP:0001061) | 2.00265796 |
| 110 | Abnormal platelet function (HP:0011869) | 1.99316118 |
| 111 | Impaired platelet aggregation (HP:0003540) | 1.99316118 |
| 112 | Vertigo (HP:0002321) | 1.99057920 |
| 113 | Chest pain (HP:0100749) | 1.98737738 |
| 114 | Abnormality of the nasal mucosa (HP:0000433) | 1.98596268 |
| 115 | Thrombocytosis (HP:0001894) | 1.98269174 |
| 116 | Sepsis (HP:0100806) | 1.97698605 |
| 117 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.97572941 |
| 118 | Abnormality of the thoracic spine (HP:0100711) | 1.96308835 |
| 119 | Abnormal platelet volume (HP:0011876) | 1.96253203 |
| 120 | Keratitis (HP:0000491) | 1.94205873 |
| 121 | Abnormality of T cells (HP:0002843) | 1.93317425 |
| 122 | Granulocytopenia (HP:0001913) | 1.93241224 |
| 123 | Keratoconjunctivitis sicca (HP:0001097) | 1.93073138 |
| 124 | Myocardial infarction (HP:0001658) | 1.92489364 |
| 125 | Skin ulcer (HP:0200042) | 1.92057033 |
| 126 | J-shaped sella turcica (HP:0002680) | 1.91519116 |
| 127 | Acute hepatic failure (HP:0006554) | 1.90847925 |
| 128 | Nasal polyposis (HP:0100582) | 1.90348245 |
| 129 | Abnormality of the pericardium (HP:0001697) | 1.90271459 |
| 130 | Viral hepatitis (HP:0006562) | 1.90028109 |
| 131 | Restrictive lung disease (HP:0002091) | 1.88833697 |
| 132 | Agammaglobulinemia (HP:0004432) | 1.88103767 |
| 133 | Polyneuropathy (HP:0001271) | 1.87762099 |
| 134 | Recurrent lower respiratory tract infections (HP:0002783) | 1.87538048 |
| 135 | Abnormality of the lumbar spine (HP:0100712) | 1.87109286 |
| 136 | Joint hemorrhage (HP:0005261) | 1.81496236 |
| 137 | Spondylolisthesis (HP:0003302) | 1.80827071 |
| 138 | Osteolytic defects of the hand bones (HP:0009699) | 1.79493102 |
| 139 | Autoimmune hemolytic anemia (HP:0001890) | 1.78068964 |
| 140 | Cheilitis (HP:0100825) | 1.75296898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.78359761 |
| 2 | MAP4K1 | 3.70230552 |
| 3 | IRAK4 | 3.69534075 |
| 4 | BLK | 3.25055052 |
| 5 | KIT | 3.00098595 |
| 6 | TYK2 | 2.70704704 |
| 7 | MAP3K14 | 2.62443875 |
| 8 | TBK1 | 2.60259808 |
| 9 | TXK | 2.47560798 |
| 10 | IRAK3 | 2.22103517 |
| 11 | FES | 2.21411612 |
| 12 | PRPF4B | 2.18728121 |
| 13 | ZAP70 | 2.17861595 |
| 14 | TAOK3 | 2.14154000 |
| 15 | CSK | 2.05470860 |
| 16 | JAK3 | 1.98892408 |
| 17 | BTK | 1.90751017 |
| 18 | TEC | 1.90322896 |
| 19 | ERN1 | 1.89206881 |
| 20 | IKBKE | 1.88619878 |
| 21 | TAOK1 | 1.87903734 |
| 22 | CSF1R | 1.87354842 |
| 23 | TGFBR2 | 1.86807253 |
| 24 | HCK | 1.84741191 |
| 25 | MAP2K3 | 1.79029065 |
| 26 | STK10 | 1.76242466 |
| 27 | JAK1 | 1.71726936 |
| 28 | SYK | 1.67488572 |
| 29 | ITK | 1.63155255 |
| 30 | CLK1 | 1.51745317 |
| 31 | IKBKB | 1.50249648 |
| 32 | FGR | 1.49695491 |
| 33 | NEK9 | 1.46159354 |
| 34 | MAP3K13 | 1.45061971 |
| 35 | LCK | 1.42391849 |
| 36 | TTN | 1.41467756 |
| 37 | EPHB1 | 1.39792500 |
| 38 | SIK2 | 1.32638420 |
| 39 | SIK3 | 1.31544960 |
| 40 | LYN | 1.27423964 |
| 41 | MAP3K1 | 1.24823119 |
| 42 | KSR2 | 1.20895513 |
| 43 | NME2 | 1.20086351 |
| 44 | CAMK1D | 1.15674801 |
| 45 | TRPM7 | 1.14536023 |
| 46 | MARK2 | 1.08084976 |
| 47 | RPS6KA4 | 1.03281856 |
| 48 | JAK2 | 1.00771205 |
| 49 | GRK6 | 1.00088009 |
| 50 | TRIB3 | 0.97935097 |
| 51 | PRKD2 | 0.95977221 |
| 52 | IRAK1 | 0.90022975 |
| 53 | PIM1 | 0.88173190 |
| 54 | STK4 | 0.87488152 |
| 55 | PKN2 | 0.85970900 |
| 56 | KDR | 0.85549620 |
| 57 | CAMK1G | 0.85121469 |
| 58 | RIPK1 | 0.82695783 |
| 59 | TAOK2 | 0.82468749 |
| 60 | MARK3 | 0.80988440 |
| 61 | PAK4 | 0.79428667 |
| 62 | IRAK2 | 0.78561234 |
| 63 | PTK6 | 0.78416954 |
| 64 | CDK19 | 0.77440966 |
| 65 | BMPR2 | 0.76625994 |
| 66 | LRRK2 | 0.75375432 |
| 67 | MATK | 0.75280055 |
| 68 | CHUK | 0.74123978 |
| 69 | MAP3K7 | 0.73969610 |
| 70 | GRK7 | 0.65810016 |
| 71 | PIM2 | 0.65696212 |
| 72 | CDC42BPA | 0.64367213 |
| 73 | EGFR | 0.64276104 |
| 74 | PTK2B | 0.64228731 |
| 75 | SMG1 | 0.63457662 |
| 76 | MAP3K2 | 0.62295199 |
| 77 | STK11 | 0.62271980 |
| 78 | FGFR3 | 0.62225293 |
| 79 | CDK6 | 0.60833025 |
| 80 | TESK2 | 0.60547669 |
| 81 | PRKCD | 0.60417197 |
| 82 | MAPK7 | 0.60395680 |
| 83 | MAP3K3 | 0.60249860 |
| 84 | MAP2K4 | 0.59803125 |
| 85 | ABL1 | 0.59614556 |
| 86 | PIK3CG | 0.57698076 |
| 87 | CDK12 | 0.57385425 |
| 88 | FYN | 0.55971013 |
| 89 | DYRK1B | 0.55741777 |
| 90 | RPS6KA6 | 0.52763299 |
| 91 | FGFR4 | 0.52740143 |
| 92 | SCYL2 | 0.52315597 |
| 93 | PDK1 | 0.52246379 |
| 94 | YES1 | 0.52232301 |
| 95 | EPHA3 | 0.51474330 |
| 96 | HIPK2 | 0.50278204 |
| 97 | STK38 | 0.50196037 |
| 98 | NEK2 | 0.49846501 |
| 99 | CAMKK2 | 0.48769846 |
| 100 | RPS6KC1 | 0.45655915 |
| 101 | RPS6KL1 | 0.45655915 |
| 102 | MAP3K11 | 0.45510322 |
| 103 | RET | 0.45307776 |
| 104 | MAP3K10 | 0.45178468 |
| 105 | PRKCQ | 0.44600994 |
| 106 | CAMKK1 | 0.43676488 |
| 107 | MAP2K6 | 0.43537226 |
| 108 | PRKCH | 0.43518377 |
| 109 | MAPKAPK2 | 0.42108641 |
| 110 | RAF1 | 0.41729221 |
| 111 | PBK | 0.41510233 |
| 112 | RPS6KA2 | 0.39516777 |
| 113 | SIK1 | 0.38855909 |
| 114 | NLK | 0.38628801 |
| 115 | KSR1 | 0.37837310 |
| 116 | EIF2AK2 | 0.37600202 |
| 117 | PDPK1 | 0.36509126 |
| 118 | FLT3 | 0.35538011 |
| 119 | CDK4 | 0.35155469 |
| 120 | DAPK2 | 0.34497585 |
| 121 | TNK2 | 0.34099951 |
| 122 | SGK2 | 0.33471584 |
| 123 | MAP3K8 | 0.33140662 |
| 124 | CDK9 | 0.31669598 |
| 125 | PRKG2 | 0.29167068 |
| 126 | IGF1R | 0.28640613 |
| 127 | PRKCZ | 0.28260387 |
| 128 | ERBB3 | 0.27237571 |
| 129 | MAPK11 | 0.26885191 |
| 130 | MOS | 0.26697326 |
| 131 | SGK3 | 0.26320835 |
| 132 | MAP3K6 | 0.25990531 |
| 133 | MAPK12 | 0.25156250 |
| 134 | MAP3K5 | 0.24906401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.43949396 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.18183476 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.69802776 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.68004314 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.64985457 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.63679808 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.28623399 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.21772468 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.17925601 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.16287536 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.12656292 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.04969647 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.04044719 |
| 14 | Measles_Homo sapiens_hsa05162 | 2.01466331 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.90645936 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.90615040 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.89901756 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.89700546 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.89555628 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85443557 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.78745009 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.72714644 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.70753666 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.66508615 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.65969908 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.64262630 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.53177644 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.53105646 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.52782974 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.52401492 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.49165471 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.47967355 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47639110 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47008271 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46743140 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.45703972 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.45284938 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.41728185 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.40952223 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35291685 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27932826 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23982688 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.23908108 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.21260811 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.17989060 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16400393 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.15674168 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09687834 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.07387189 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 0.98327333 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96090524 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95137336 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94749921 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91359256 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.90307827 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82690553 |
| 57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82149552 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82069233 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79612186 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77602436 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75447637 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75188790 |
| 63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69610597 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67785928 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66794427 |
| 66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64172796 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.63723517 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.62455205 |
| 69 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62242801 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60568143 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60490899 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60436840 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58921778 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58228165 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57829029 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56793054 |
| 77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56739210 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55522912 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54950337 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53958873 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52222139 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.50603553 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50402901 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49231876 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49206929 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48659601 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48274182 |
| 88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47675254 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46246809 |
| 90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44922172 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43947780 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41959027 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41156413 |
| 94 | DNA replication_Homo sapiens_hsa03030 | 0.40152194 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40038722 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39920866 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37959875 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36848040 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33742826 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33494145 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33341009 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.32992930 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30380630 |
| 104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.30309910 |
| 105 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30126811 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.26824282 |
| 107 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.26388387 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24713570 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23709571 |
| 110 | Base excision repair_Homo sapiens_hsa03410 | 0.22494822 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.21458611 |
| 112 | ABC transporters_Homo sapiens_hsa02010 | 0.21445474 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20157668 |
| 114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20098057 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20006371 |

